A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults

Completed · Phase 1

Conditions studied: Safety Issues

In brief

A Phase 1 Non-Randomized Open Label Study of Oral ICM20

Key facts

Study ID
NCT05523596
Run by
IC-MedTech Corporation
People needed
13
Starts
2023-08-20
Expected to finish
2025-10-03
Last updated by the study team
2026-04-16

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.